Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 134Carcinoma, Non-Small-Cell Lung 133Prostatic Neoplasms 87Lung Neoplasms 43Neoplasms 31Squamous Cell Carcinoma of Head and Neck 30Neoplasm Metastasis 29Stomach Neoplasms 26Head and Neck Neoplasms 24Esophageal Neoplasms 20Parkinson Disease 4, Autosomal Dominant Lewy Body 17Pancreatic Neoplasms 17Ovarian Neoplasms 16Urinary Bladder Neoplasms 13Sarcoma 12Adenocarcinoma of Lung 9Triple Negative Breast Neoplasms 8Fallopian Tube Neoplasms 8Carcinoma, Transitional Cell 8Carcinoma, Ovarian Epithelial 8Adenocarcinoma Of Esophagus 7Recurrence 6Inflammatory Breast Neoplasms 5Carcinoma, Squamous Cell 5Carcinoma 5Breast Neoplasms, Male 5Adenocarcinoma, Bronchiolo-Alveolar 5Laryngeal Neoplasms 4Esophageal Squamous Cell Carcinoma 4Advanced Solid Tumors 4

Interventions

Ifosfamide 10Carboplatin 8Paclitaxel 7Etoposide 7Filgrastim 5Dexamethasone 3Cisplatin 3Thiotepa 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Ondansetron 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2Calcium Dobesilate 2Bleomycin 2Aprepitant 2tremelimumab 1thymoglobulin 1sodium thiosulfate 1poly ICLC 1pembrolizumab 1pegfilgrastim 1palifosfamide lysine 1palbociclib 1isophosphamide mustard 1fosaprepitant 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Testicular Neoplasms × Docetaxel × Clear all
NCT00936936 2024-08-26

High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors

M.D. Anderson Cancer Center

Phase 2 Completed
64 enrolled 10 charts
Genitourinary

Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡